EBP, EBP cholestenol delta-isomerase, 10682

N. diseases: 243; N. variants: 42
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE The mutation on EBP can cause Conradi-Hunermann syndrome, an inborn error. 31165728 2019
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease BEFREE X-linked dominant chondrodysplasia punctata type 2 (CDPX2) is a condition involving facial, skin, and skeletal dysplasia as a result of a mutation in emopamil binding protein (EBP). 30608402 2019
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE New splicing pathogenic variant in EBP causing extreme familial variability of Conradi-Hünermann-Happle Syndrome. 30135486 2018
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease UNIPROT The aim of our study is to identify EBP mutation in a unique case of Conradi-Hünermann-Happle syndrome with rare psoriasiform lesions. 25814754 2015
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata (CP) caused by mutations in one gene of the distal pathway of cholesterol biosynthesis. 24036494 2014
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE These males exhibit a phenotype similar to CDPX2 due to either somatic mosaicism or a 47, XXY karyotype in association with a null EBP allele. 24700572 2014
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Mutations in EBP have previously been associated with Conradi-Hunermann-Happle syndrome (CHH), an X-linked dominant disorder characterized by skeletal dysplasia, skin, and ocular abnormalities, which is usually lethal in males. 24459067 2014
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata which primarily affects the skin, bones and eyes. 22121851 2012
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Conradi-Hünermann-Happle syndrome is caused by mutations in the gene EBP encoding Δ(8)-Δ(7) sterol isomerase emopamil-binding protein. 21931045 2011
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Mutations in the EBP gene cause X-linked dominant chondrodysplasia punctata (CDPX2) which can be considered as a phenocopy of warfarin embryopathy. 21103663 2011
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Mutations of the gene coding for emopamil binding protein (EBP) can lead to deficient activity of 3-β-hydroxysteroid Δ(8), Δ(7) isomerase and are most commonly identified in. association with the X-linked dominant (male lethal) chondrodysplasia punctata (CDPX2), also known as Conradi-Hunermann syndrome. 20949533 2010
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease BEFREE Three were microdeletions eliminating PORCN and encompassing neighboring genes such as EBP, the gene associated with Conradi-Hünermann-Happle syndrome (CDPX2). 19309688 2009
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease CTD_human Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene. 18176751 2008
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene. 18176751 2008
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Two novel EBP mutations in Conradi-Hünermann-Happle syndrome. 18573709 2008
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease UNIPROT Diagnosis of Conradi-Hünermann-Happle syndrome was confirmed by plasma sterol analysis showing markedly elevated levels of 8(9)-cholestenol and 8-dehydrocholesterol and by detection of a missense mutation (c.307G>A; p.E103K) in the emopamil-binding protein gene. 18176751 2008
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Prenatal testing for a novel EBP missense mutation causing X-linked dominant chondrodysplasia punctata. 18395876 2008
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Molecular genetic analysis of the EBP gene revealed a nonsense mutation (c.328C>T, p.R110X), which was previously detected in one CDPX2 patient and in a second female patient, who was only affected on one body side and erroneously diagnosed as CHILD syndrome. 17625999 2007
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Novel EBP gene mutations in Conradi-Hünermann-Happle syndrome. 17949453 2007
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease BEFREE This study demonstrates that EBP is the gene responsible for CDPX2 across different populations and extends the total number of confirmed mutations to 55. 15953085 2005
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease BEFREE Prior to the recent characterization of the enzymatic defect and identification of the involved gene, the histopathology of X-linked dominant chondrodysplasia punctata (Conradi-Hünermann-Happle syndrome or CDPX2) has been described under various names including calcinosis universalis, chondrodystrophia calcificans congenita, Conradi disease, and Conradi-Hünermann syndrome. 14726822 2004
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP. 12503101 2003
Chondrodysplasia punctata, X-linked dominant type
1.000 Biomarker disease GENOMICS_ENGLAND Plasma sterol analysis was a highly specific and sensitive indicator of the presence of an EBP mutation in females with suspected CDPX2, including a clinically unaffected mother of a sporadic case. 12509714 2003
Chondrodysplasia punctata, X-linked dominant type
1.000 GeneticVariation disease BEFREE CDPX2 results from mutation of an X-linked gene coding for sterol-delta(8)-delta(7) isomerase (emopamil binding protein). 12503102 2003